- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06553989
Impact on Quality of Life of Osteopathic Visceral Mobilizations After Endometriosis Surgery (MOVENDOP)
January 31, 2025 updated by: University Hospital, Clermont-Ferrand
Impact on Quality of Life of Osteopathic Visceral Mobilizations in Patients Undergoing Post-operative ENDOmetriosis Surgery
One of the most common post-operative complications of gynaecological surgery, and in particular endometriosis surgery, is the formation of peritoneal adhesions.
After laparotomy, it affects up to 90% of patients.
Minimally invasive techniques (such as laparoscopy) reduce the risk of adhesion formation, but cannot totally prevent it.
Adhesions can lead to chronic pelvic pain, dyspareunia, digestive disorders and infertility.
Various strategies and devices have been developed to try and limit adhesion formation, but their effectiveness has not been fully proven in the literature.
The only real treatment for adhesions is adhesiolysis, although adhesions often reform.
The quality of surgery remains the best means of preventing adhesion formation.
To reduce the morbidity associated with pelvic adhesions, it is essential to develop alternative, non-invasive, anti-adhesive methods such as manual osteopathic visceral mobilization.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
63
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lise Laclautre
- Phone Number: 334.73.754.963
- Email: promo_interne_drci@chu-clermontferrand.fr
Study Locations
-
-
-
Clermont-Ferrand, France
- Recruiting
- CHU de Clermont-Ferrand
-
Principal Investigator:
- Nicolas Bourdel
-
Contact:
- Lise LACLAUTRE
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Woman of legal age
- Indication for surgery for infiltrating endometriosis
- Able to give informed consent to participate in research
- Patient included in NO ENDO (national endometriosis observatory promoted by Clermont-Ferrand University Hospital)
Exclusion Criteria:
- Indication for surgery for superficial endometriosis
- Patient of legal age, under guardianship or trusteeship
- Pregnant or breast-feeding patient
- Patients not affiliated to the social security system
- Patients who do not speak French
- Patients under court protection
- Simultaneous participation in another study
- Refusal to participate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
patients operated for endometriosis without osteopathic visceral mobilization
|
|
|
Experimental: Experimental group
patients operated for endometriosis with osteopathic visceral mobilization
|
a combination of breathing and visceral mobilizations
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life with the EHP-30 questionnaire score
Time Frame: 1 year
|
Percentage change in baseline questionnaire score (EHP-30) between pre-operative visit and 1 year. The EHP-30 contains 30 items and ranges from 0 (best health) to 100 (worst health). The items in the baseline questionnaire are grouped into 5 main sub-domains: pain, control and powerlessness, emotional well-being, social support and self-image. |
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
quality of life with score of the questionnaire EHP-30
Time Frame: pre-operative, 6 months and 12 months
|
Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations
|
pre-operative, 6 months and 12 months
|
|
quality of life with score of the questionnaire GIQLI
Time Frame: pre-operative, 6 months and 12 months
|
Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations
|
pre-operative, 6 months and 12 months
|
|
quality of life with score of the questionnaire FSFI
Time Frame: pre-operative, 6 months and 12 months
|
Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations
|
pre-operative, 6 months and 12 months
|
|
quality of life with score of the questionnaire ICIQ-FLUTS
Time Frame: pre-operative, 6 months and 12 months
|
Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations
|
pre-operative, 6 months and 12 months
|
|
quality of life with score of the questionnaire PCS
Time Frame: pre-operative, 6 months and 12 months
|
Compare changes in patients' quality of life between the control group and the experimental group with visceral mobilizations
|
pre-operative, 6 months and 12 months
|
|
pelvic pain
Time Frame: pre-operative, 6 hours after surgery, 1 day after surgery, 1 month after surgery, 6 months and 12 months
|
Compare pelvic pain between the 2 groups using EVA Scale (Visual Analogic Scale (from 0 : no pain to 10 : worst pain possible)
|
pre-operative, 6 hours after surgery, 1 day after surgery, 1 month after surgery, 6 months and 12 months
|
|
quality of life with the sub-domains of the EHP-30 questionnaire
Time Frame: pre-operative, 6 months and 12 months
|
Compare changes in patients' quality of life between the 2 groups regarding the sub-domains the EHP-30 questionnaire
|
pre-operative, 6 months and 12 months
|
|
evaluation of the cicatrisation
Time Frame: post operative, 6 months and 12 months
|
Examination of scar appearance by the surgeon : acquired healing, healing in progress or disunion
|
post operative, 6 months and 12 months
|
|
evaluation of the abdominal flexibility
Time Frame: 1 year
|
Evaluation of abdominal flexibility with an EVA scale in the regions: right and left iliac fossa, hypogastrium at one year assessed by an independent osteopath between 0 and 10 (0 corresponding to normal flexibility and 10 to total rigidity).
|
1 year
|
|
Use of additional care
Time Frame: 1 year
|
Compare the use of additional care between the 2 groups by collecting data on the type of consultations (gynecologist, general practitioner, midwife, pain center doctor, emergency doctor, osteopath, physiotherapist, acupuncturist, magnetizer, hypnotherapist, healer, ...) and the number of visits
|
1 year
|
|
consumption of analgesics and hormonal treatment
Time Frame: 1 year
|
Compare the consumption of analgesics and hormonal treatment (name and dose of the medication) between the 2 groups
|
1 year
|
|
fertility
Time Frame: 1 year
|
Achieving pregnancy during the first postoperative year (yes or no)
|
1 year
|
|
number of days of sick leave
Time Frame: 1 year
|
Compare the number of days of sick leave between the two groups
|
1 year
|
|
compare patient profiles using the sub-domains of the EHP-30 questionnaire
Time Frame: 1 year
|
In the experimental group, identify patient profiles based on the sub-domains of quality of life assessed during the pre-operative visit, and compare these different groups according to the improvement in patients' post-operative quality of life at one year.
|
1 year
|
|
patient compliance
Time Frame: 1 year
|
evaluate the impact of compliance of patients in the visceral mobilization group on improved quality of life and abdominal flexibility (by collecting the number of osteopathic self-mobilizations performed each month following surgery and during1 year)
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nicolas Bourdel, University Hospital, Clermont-Ferrand
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 27, 2025
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2028
Study Registration Dates
First Submitted
August 8, 2024
First Submitted That Met QC Criteria
August 12, 2024
First Posted (Actual)
August 14, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 31, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RBHP 2023 BOURDEL
- 2023-A02653-42 (Other Identifier: 2023-A02653-42)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometriosis
-
Fabio BarraCompletedEndometriosis | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis Pelvic | Endometriosis of ColonItaly
-
BioGene Pharmaceutical Ltd.WithdrawnSafety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (ELTA)Endometriosis | Endometriosis Ovary | Endometriosis, Rectum | Endometriosis ExternaSwitzerland
-
Ospedale Policlinico San MartinoCompletedEndometriosis | Bowel Endometriosis | Endometriosis, Rectum | Endometriosis ColonItaly
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of PleuraItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis, Rectum | Endometriosis, SigmoidItaly
-
Semmelweis UniversityUniversity of PecsNot yet recruitingEndometriosis | Endometriosis Ovary | Endometriosis Rectovaginal Septum
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownBowel Endometriosis | Endometriosis, RectumItaly
-
Ospedale Policlinico San MartinoActive, not recruitingEndometriosis, Rectum | Endometriosis of ColonItaly
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
Clinical Trials on osteopatic visceral mobilization
-
University of SorocabaCompleted
-
University of SorocabaCompletedStroke Rehabilitation
-
Cairo UniversityCompleted
-
University Hospital, GhentWithdrawn
-
Laval UniversityRecruitingFood Preferences | Adiposity | Eating BehaviorCanada
-
Ulrich Ronellenfitsch, MDTerminated
-
Azusa Pacific UniversityRecruitingDysmenorrhea | Visceral Pain | Menstrual Pain | Dysmenorrhea PrimaryUnited States
-
Poznan University of Physical EducationUniversity of Life Science in PoznanRecruitingProlapse; Female | Endometriosis-related PainPoland
-
Instituto Docusse de Osteopatia e Terapia ManualCompletedHealthy VolunteersBrazil